Le Lézard
Classified in: Health, Sports and recreation
Subject: AWD

John Vitolo, M.D. Named NJ Top Doc For Eight Consecutive Years


SCOTCH PLAINS, N.J., June 14, 2018 /PRNewswire-PRWeb/ -- Dr. John Vitolo of Advocare Orthopedic and Sports Medicine Center has been reviewed and approved by NJ Top Docs for the eighth consecutive year. Dr. Vitolo is a board certified orthopedic surgeon with a subspecialty in sports medicine.

Dr. Vitolo is a former team orthopedic surgeon for the Boston Red Sox and he completed medical training at the University of Massachusetts Medical Center where he treated many well-known professional athletes. Dr. Vitolo is also one of a select group of orthopedic surgeons who were selected by Rutgers University to provide clinical training to student physicians.

A few of the professional memberships that Dr. Vitolo is part of include the American Academy of Orthopedic Surgeons, the Arthroscopy Association of North America, and the New Jersey Orthopedic Society.

Services provided by Dr. Vitolo include treatment of all sports injuries, ACL Repair, Meniscal Tears/Repairs, Collateral Ligament Sprains, Shoulder Impingement/Bursitis and so much more.

For a full list of Dr. Vitolo's services, please click here: https://njtopdocs.com/nj-doctors/AdvocareOrtho/

About Us

NJ Top Docs a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook and Twitter

 

SOURCE NJ Top Docs


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: